Thermo Fisher Scientific announced an update to its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to enable direct detection of the Omicron SARS-CoV-2 variant.
The company said the panel includes a customizable menu of real-PCR genotyping assays to identify known SARS-COV-2 variants in just over an hour.
Labs can choose from a menu of over 50 known mutations of SARS-CoV-2 to build their unique panel, which is designed to be highly scalable, and run up to several hundred samples to monitor for one or multiple mutations simultaneously.
The panel is for research use only.
